The Alberta government says it’s taking steps to improve the health of women and children by following through on a promise to spend $26 million on research and expanding a newborn …
A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, …
A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state …
A Colorado board voted unanimously Friday to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible …
Colorado’s new prescription drug review board decided in a first-in-the-nation vote that a medication costing more than $200,000 a year doesn’t qualify as “unaffordable,” based on the drug’s benefits to …
MHRA grants License extension for cystic fibrosis medications, bringing renewed hope to families battling the condition. In a landmark decision that brings hope to young families battling cystic fibrosis, the …